Hemolytic anemia

Background

  • Wide variety of clinical presentation given the large differential diagnosis
  • Clinical presentation and lab findings differ depending on intravascular vs. extravascular hemolysis, acute vs. chronic
  • Common findings
    • low hemoglobin and hematocrit
    • reticulocytosis
    • elevated indirect bilirubin
  • Most important lab to elucidate diagnosis is blood smear
  • Most common emergent presentations are due to acute intravascular hemolytic anemias

Etiologies

Divided by etiology: acquired vs. hereditary

Clinical Features

History

PMH

Physical Exam

Differential Diagnosis

Acquired Hemolytic Anemia

Microangiopathic Hemolytic Anemia

Autoimmune

Infection

Other

  • Brown recluse spider venom

Hereditary/Congenital Hemolytic Anemia

Evaluation

Workup

  • CBC
    • Low hemaglobin/hematocrit
    • Low platelet count → microangiopathic hemolytic anemia
  • Blood smear
  • Reticulocyte count
  • CMP
    • Most important: indirect bilirubin and creatinine
  • UA (for hemoglobin, hemosiderin), uHCG
  • PT/INR
  • Hemolysis labs
    • LDH
    • Haptoglobin
    • Fibrinogen
  • Direct Anti-Globulin Test or Coombs test
  • If concern for Malaria:
    • Thick and thin prep
    • Parasitemia
  • HIV
  • Blood cultures, urine cultures
  • Consider LP if neuro symptoms

Lab Interpretation

Microangiopathic Hemolytic Anemia H/H Platelets Indirect Bili Creatinine Blood Smear PT/INR LDH Haptoglobin Fibrinogen DAT/Coombs Test Thick/Thin Prep
HUSlowlowelevatedhighly elevatedschistocyteswnlelevatedlowwnlnegativenegative
TTPlowlowelevatedelevatedschistocyteswnlelevatedlowwnlnegativenegative
DIClowlowelevatedelevatedschistocyteselevatedelevatedlowlownegativenegative
Malignant Hypertensionlowlowelevatedvariableschistocyteselevatedlownegativenegative
Autoimmune H/H Platelets Indirect Bili Creatinine Blood Smear PT/INR LDH Haptoglobin Fibrinogen DAT/Coombs Test Thick/Thin Prep
Warm Antibody AHAlowwnlelevatedspherocyteselevatedlowwnlpositivenegative
Infection H/H Platelets Indirect Bili Creatinine Blood Smear PT/INR LDH Haptoglobin Fibrinogen DAT/Coombs Test Thick/Thin Prep
Malarialowwnlelevatedsee thick/thin prepvariableelevatedlowwnlnegativeparacytes
Babesiasee thick/thin prepnegativeparacytes
Other H/H Platelets Indirect Bili Creatinine Blood Smear PT/INR LDH Haptoglobin Fibrinogen DAT/Coombs Test Thick/Thin Prep
Brown recluselowwnlelevatedelevatedpositivenegative

Management

  • ABC’s and resuscitation if necessary, 2 large bore IVs
  • Emergent hematology consultation if patient is very ill appearing

Acquired Hemolytic Anemia

Microangiopathic Hemolytic Anemia

  • HUS
    • Supportive Care
      • Hydration
      • Pain control
    • Hemodialysis if acute renal failure
    • Do NOT give antibiotics: results in increased expression of Shiga Toxin from E. Coli O157:H7
  • TTP
    • Avoid platelet transfusion, except in life-threatening bleeding or intracranial hemorrhage
    • Plasma exchange
    • If Plasma exchange cannot be performed immediately, give FFP and plasmapharese later.
    • Factor VIII concentrate
  • DIC
    • Platelet transfusion if count is <50,000 and/or significant bleeding
    • pRBC if active bleeding or hemodynamically unstable
    • FFP if active bleeding
    • Cryoprecipitate if fibrinogen <150 and bleeding
    • TXA is only indicated for active or massive bleeding
  • Malignant hypertension
    • Reduce blood pressure as clinically indicated

Autoimmune

  • Warm antibody autoimmune hemolytic anemia
    • High-dose corticosteroids PO (1-2mg/kg per day for 3-4 weeks)
    • Monoclonal antibodies and immunosuppressive agents
    • Plasma exchange for severe hemolysis
    • Allogeneic RBC transfusion for life-threatening anemia

Infection

  • Malaria
  • Babesia
    • Mild/moderate Disease
    • Severe Disease
      • Clindamycin 300-600mg IV QID OR 600mg PO TID AND
      • Quinine 650mg PO TID x7-10 days
      • Consider exchange transfusion if parasitemia >10%
    • Supportive treatment

Other

  • Brown recluse spider bite
    • Supportive care
      • Hemodynamic support with fluids and pressers if necessary
      • Blood product transfusion if necessary

Hereditary/Congenital Hemolytic Anemia

  • G6PD
    • Stop new medications
    • Treat any infections aggressively
    • Ovoid oxidant drugs
    • Blood transfusion if severe illness
  • Sickle Cell Disease, Thalassemia, Hereditary spherocytosis
    • Hemolytic anemia in the above diseases typically chronic, usually does not require treatment in ED

Disposition

  • Depends on severity, complications, etc.

See Also


References

    This article is issued from Wikem. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.